The PE Ratio as of December 2025 (TTM) for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is 152.35

According to Vcanbio Cell & Gene Engineering Corp., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 152.35. This represents a change of 245.50% compared to the average of 44.10 of the last 4 quarters.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Historical PE Ratio (quarterly & annually)

How has 600645.SS PE Ratio performed in the past?

The mean historical PE Ratio of Vcanbio Cell & Gene Engineering Corp., Ltd over the last ten years is 185.34. The current 152.35 PE Ratio has changed 8.12% with respect to the historical average. Over the past ten years (40 quarters), 600645.SS's PE Ratio was at its highest in in the March 2020 quarter at 463.75. The PE Ratio was at its lowest in in the December 2022 quarter at -1272.62.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vcanbio Cell & Gene Engineering Corp., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Average PE Ratio

How has 600645.SS PE Ratio performed in the past?

The current PE Ratio of Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) PE Ratio vs. Peers

How is 600645.SS’s PE Ratio compared to its peers?

Vcanbio Cell & Gene Engineering Corp., Ltd’s PE Ratio is less than Jinyu Bio-technology Co., Ltd. (159.74), greater than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (8.90), greater than Zhejiang Jolly Pharmaceutical Co.,LTD (19.67), less than Hualan Biological Bacterin Inc. (163.22), greater than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (24.76), greater than Shanghai Haohai Biological Technology Co., Ltd. (26.62), greater than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (35.70), greater than Chengdu Easton Biopharmaceuticals Co., Ltd. (41.38), less than Chengdu Olymvax Biopharmaceuticals Inc. (159.99), greater than Chengdu Kanghua Biological Products Co., Ltd. (53.30),

Build a custom stock screener for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vcanbio Cell & Gene Engineering Corp., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vcanbio Cell & Gene Engineering Corp., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.